10 Healthcare Technologies to Keep an Eye On10 Healthcare Technologies to Keep an Eye On

January 22, 2015

11 Slides
10 Healthcare Technologies to Keep an Eye On

Already have an account?

2. Artificial PancreasIn September 2013, Medtronic debuted the MiniMed 530G, which it billed as a first-generation artificial pancreas. But rather than being a huge leap forward, the 530G looked more like an incremental step. Still, the device was the first first artificial pancreas to be approved by the FDA under its critical path initiative.“FDA has taken several initiatives to speed development of true [artificial pancreas device systems (APDSs)], and you can expect to see more devices on the way within one to three years,” ECRI says in its report.Major competitors include Johnson & Johnson's Animas Corp., which late last year won FDA approval for its Animas Vibe insulin pump and continuous glucose monitoring (CGM) system. Boston Scientific has also been active in the field.Diabetics eagerly want better technologies to manage their condition. Some have even engaged in hacking their own devices.Continue to next technology>>

10 Healthcare Technologies to Keep an Eye On

Oracle, soothsayer, augur, visionary—it sure seems one would have to have one of those jobs to figure out how disruptive changes in healthcare are going to affect the medical device industry.

That isn’t stopping analysts from having a try at figuring out what the future has in store, including recent reports, one from the ECRI Institute and another from PricewaterhouseCoopers.

Just look at the number of consumer electronics and other types of companies showing an interest in healthcare, and odds are that some disruption could be on the way, says Will Falk, North and South America healthcare leader at Pricewaterhousecoopers (PwC).

“If you look at the 50 biggest companies in the world, 14 were already healthcare companies. Of the other 36, 24 now all have healthcare strategies. If Apple and Samsung and Verizon and General Motors all enter your business, you’re going to want to take notice of that and understand what that means,” Falk says.

Here are 10 trends culled from the ECRI and PwC reports that you should especially be aware of. >>

Chris Newmarker is senior editor of MPMN and Qmed. Follow him on Twitter at @newmarkerBrian Buntz is the editor-in-chief of MPMN and Qmed. Follow him on Twitter at @brian_buntz.

Like what you’re reading? Subscribe to our daily e-newsletter.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like